CRLEarnings Release财报快讯Media source媒体来源Source link原始来源by InvestLog AIInvestLog AI 整理

Event time: 事件时间：04/11/2026 12:00:00 UTC2026/11/04 12:00:00 UTC

Published: 文章发布：04/11/2026 12:48:30 UTC2026/11/04 12:48:30 UTC

CRL earnings release — EPS beat +4.0% · revenue beat +2.3%查尔斯河 (CRL) 财报发布 — EPS 高于预期+4.0% · 营收高于预期+2.3%

Key Results

EPS: $3.09 vs $2.97 estimate, beat+4.0%.

Revenue: $983M vs $960M estimate, beat+2.3%.

Period: 2026 Q3 period ended 2026-09-26

Revenue: $983M; YoY: -2.2%; QoQ: -2.1%

Operating income: $203M; Operating margin: 20.6%; YoY: +51.4%; QoQ: +69.0%

Net income: $333M; GAAP diluted EPS: $6.86; YoY: +512.0%; QoQ: +22574.2%

Operating cash flow: $254M; Capex: $47M; Free cash flow: $207M

Cash: $200M; Total debt: $2.8B; Net debt: $2.6B

Official release: Charles River Laboratories Announces Third-Quarter 2026 Results

EPS：$3.09 vs $2.97 预期，高于预期+4.0%。

营收：$983M vs $960M 预期，高于预期+2.3%。

期间：2026 Q3（截至 2026-09-26）

营收：$983M；同比：-2.2%；环比：-2.1%

经营利润：$203M；经营利润率：20.6%；同比：+51.4%；环比：+69.0%

净利润：$333M；GAAP 稀释 EPS：$6.86；同比：+512.0%；环比：+22574.2%

经营现金流：$254M；资本开支：$47M；自由现金流：$207M

现金：$200M；总债务：$2.8B；净债务：$2.6B

For information only. Not investment advice.内容仅供参考，不构成投资建议。